−1.18SEK
−44.61 MSEK
1.36 MSEK
53.58 M
About ENORAMA PHARMA AB
Sector
CEO
Annette Agerskov
Headquarters
Malmö
Website
Founded
2006
ISIN
SE0008216329
FIGI
BBG00CVRYPV2
Enorama Pharma AB engages in the research, development and manufacture of pharmaceutical drug delivery system. It offers medicated chewing gums for people having difficulty swallowing tablets or who may have various problems with digestion. The company was founded by Mats-Olle Rönngard on November 28, 2006 and is headquartered in Malmo, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ERMA is 2.90 SEK — it has decreased by 11.31% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ENORAMA PHARMA AB stocks are traded under the ticker ERMA.
Yes, you can track ENORAMA PHARMA AB financials in yearly and quarterly reports right on TradingView.
Like other stocks, ERMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENORAMA PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ENORAMA PHARMA AB EBITDA is −38.29 M SEK, and current EBITDA margin is −2.82 K%. See more stats in ENORAMA PHARMA AB financial statements.